C4 Therapeutics presents molecular glue discovery platform at targeted protein degradation summit
CCCC•C4 Therapeutics will present its DNA-encoded library technology for discovering molecular glue degraders, including findings on the VAV1 target, at a summit in Boston on October 29, 2026.
1. Summit presentation
C4 Therapeutics will present at the 9th Annual Targeted Protein Degradation Summit in Boston on October 29, 2026. The presentation will highlight its DNA-encoded library technology for discovering molecular glue degraders, including findings on the VAV1 target.
